Jobs at Intellia Therapeutics

Lead enterprise QMS strategy and digital compliance for ATMPs and biologics, drive eQMS implementation and CSV, ensure global regulatory and inspection readiness, establish data governance and analytics, manage enterprise risk, and build a high-performing quality organization across clinical to commercial stages.

Lead global transformation of QMS and digital compliance to support commercialization. Set strategic direction, govern global QMS, implement GxP standards across modalities, manage inspection readiness, drive risk-based compliance, define KPIs and analytics, ensure 21 CFR 11/Annex 11/GAMP 5 system compliance, and lead a high-performing cross-functional quality team.

The Associate Director Data Architect is responsible for managing enterprise integrations, establishing standards, driving automation, and ensuring secure, scalable connectivity across IT systems.

Lead commercial launch for an in vivo CRISPR therapy across LA, MS, and AL. Develop territory plans, build KOL relationships, present Phase III data, manage complex treatment pathways, coordinate hub and payer access, and collaborate cross-functionally to drive patient treatment completion and market adoption.

Lead commercial launch and territory management for an in vivo CRISPR therapy for HAE in Long Island. Develop territory plans, build KOL and account relationships, present clinical data, educate on CRISPR MOA, manage complex treatment pathways and hub integration, coordinate cross-functionally (Medical Affairs, Market Access), and drive adoption through strategic account and launch execution.

Lead commercial launch of an in vivo CRISPR therapy for HAE across NC, SC, and TN. Develop territory plans, build relationships with immunologists/allergists and treatment centers, present Phase III data, educate on CRISPR MOA, manage complex treatment pathways and patient hub integration, coordinate with medical affairs and market access, and drive account activation and long sales-cycle commercialization.

Lead commercial launch and territory commercialization for an in vivo CRISPR therapy across Pennsylvania and West Virginia. Develop territory plans, build KOL and account relationships, present clinical data, educate providers on CRISPR MOA, coordinate patient access and hub services, gather competitive intelligence, and collaborate with Medical Affairs and Market Access to drive patient treatments and coverage.

Lead the commercial launch of an in vivo CRISPR therapy for HAE in Southern Texas. Develop and execute territory and account plans, build KOL relationships, present Phase III data, manage complex treatment pathways, coordinate with Medical Affairs and Market Access, and drive patient access, site activation, and adoption through strategic account and pipeline management.

Lead commercial launch of an in vivo CRISPR therapy across California and Hawaii. Develop territory plans, build relationships with immunologists/allergists and HAE centers, present Phase III data, educate on CRISPR MOA, manage complex treatment pathways and hub integration, coordinate cross-functionally with Medical Affairs and Market Access, and execute account strategies to drive patient treatment uptake.

Lead commercial launch and territory commercialization of a first-in-class in vivo CRISPR therapy for HAE across Northern California. Develop territory plans, build KOL relationships, present clinical data, manage complex treatment pathways and hub integration, collaborate with Medical Affairs and Market Access, and drive account activation and patient access.

Lead commercial launch of an in vivo CRISPR therapy for HAE in the Los Angeles territory. Develop territory and account plans, build KOL relationships, present clinical data, educate providers on CRISPR and disease management, coordinate patient access/hub services, gather competitive intelligence, and work cross-functionally with medical affairs and market access to drive patient treatment completion.

Field commercial leader responsible for launching an in vivo CRISPR therapy across WA, OR, and AK. Develop territory plans, build KOL relationships, present Phase III clinical data, manage complex treatment pathways, coordinate hub and reimbursement support, and collaborate cross-functionally to drive patient access and uptake in a rare disease market.

Lead the commercial launch of an in vivo CRISPR therapy for hereditary angioedema across Northern Texas. Develop territory plans, prioritize accounts, build KOL relationships, present Phase III data, educate providers on CRISPR MOA, manage complex patient treatment pathways, coordinate hub and reimbursement services, and collaborate with Medical Affairs and Market Access to drive access and uptake.

Lead commercial launch of an in vivo CRISPR therapy across MO, IL, and IN. Develop territory plans, build KOL and institutional relationships, present Phase III clinical data, educate providers on CRISPR MOA, manage complex treatment pathways and hub integration, align with Medical Affairs and Market Access, and drive adoption in a rare-disease market with long sales cycles.

Lead commercial launch and territory management for an in vivo CRISPR therapy for HAE across a multi-state territory. Build KOL relationships, present Phase III data, drive account development and patient pathway coordination, partner with medical affairs and market access, and execute launch and reimbursement strategies for a first-in-class gene editing treatment.

Lead commercial launch of an in vivo CRISPR therapy across Florida and Puerto Rico. Develop territory plans, build KOL relationships, present clinical data, educate providers on CRISPR and HAE management, manage complex treatment pathways and hub integration, coordinate with Medical Affairs and Market Access, and drive patient access and uptake through strategic account development and competitive differentiation.

Lead the commercial launch of an in vivo CRISPR therapy for HAE across NY/VT/CT. Build territory plans, prioritize accounts, educate HCPs on CRISPR mechanism and clinical data, manage pipeline and patient journey, coordinate hub services, gather competitive intelligence, and collaborate with Medical Affairs and Market Access to drive treatment adoption and access.

Manage administration, support, enhancement, and optimization of Veeva commercial and medical platforms. Act as liaison between business, IT, and vendors; translate requirements into technical solutions; lead UAT, impact assessments, process improvements, documentation, and compliance alignment (FDA/HIPAA). Provide technical leadership and oversee incident resolution and integrations.

Lead commercial launch and territory commercialization for an in vivo CRISPR HAE therapy across North Florida. Develop territory plans, build KOL and institutional relationships, present Phase III clinical data, educate providers on CRISPR MOA, manage complex treatment and patient pathways, coordinate hub services and cross-functional teams, and execute competitive and access strategies to drive patient treatments.

Lead the commercial launch of an in vivo CRISPR therapy for HAE in the Cleveland territory. Build and prioritize accounts, educate clinicians on CRISPR MOA and Phase III data, manage complex patient pathways and hub integration, coordinate with Medical Affairs and Market Access, and drive uptake through strategic relationships and competitive differentiation.